HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on LifeMD (NASDAQ: LFMD) and maintained a price target of $9 for the stock. This endorsement reflects confidence in the company's performance and potential growth.